10 Years of Excellence
Founded in 2003 and based in Rockville, MD, TriStar has pioneered the use of very high-density tissue arrays for truly large-scale analysis of gene/protein expression in human normal and cancer tissues. Our customers can now obtain valuable data and IP around the expression or amplification of their targets in statistically powerful numbers of high quality tissues with annotated clinical data. Essentially, we give “Clinical Significance to Molecular Targets”.
An emerging unmet need in oncology drug development today is service providers that offer both access to well-annotated specimens and sophisticated molecular analytical capabilities. We have aimed to address this by offering a range of services, histology labs, analytical platforms and access top academic opinion leaders. We offer our customers distinct advantages.